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Abstract
Rationale Methylphenidate inhibits the reuptake of dopa-
mine and noradrenaline and is used to treat children with
attention deficit hyperactivity disorder (ADHD). Besides
reducing behavioral symptoms, it improves their cognitive
function. There are also observations of methylphenidate-
induced cognition enhancement in healthy adults, although
studies in this area are relatively sparse. We assessed the
possible memory-enhancing properties of methylphenidate.
Objective In the current study, the possible enhancing effects
of three doses of methylphenidate on declarative and working
memory, attention, response inhibition and planning were
investigated in healthy volunteers.
Methods In a double blind placebo-controlled crossover
study, 19 healthy young male volunteers were tested after a
singledose of placebo or 10, 20 or 40 mg of methylphenidate.
Cognitiveperformancetestingincludedawordlearningtestas
a measure of declarative memory, a spatial working memory
test, a set-shifting test, a stop signal test and a computerized
version of the Tower of London planning test.
Results Declarative memory consolidation was significantly
improved relative to placebo after 20 and 40 mg of methyl-
phenidate. Methylphenidate also improved set shifting and
stopped signal task performance but did not affect spatial
working memory or planning.
Conclusions To the best of our knowledge, this is the first
study reporting enhanced declarative memory consolidation
after methylphenidate in a dose-related fashion over a dose
range that is presumed to reflect a wide range of dopamine
reuptake inhibition.
Keywords Methylphenidate.Dopamine.Declarative
memoryconsolidation
Introduction
Cognition enhancement has received much attention in recent
scientific literature due to our aging society and the increasing
prevalence of Alzheimer’s disease. However, the healthy
young population also engages in drug use to enhance cogni-
tionasisillustrated bytheabundantillicit use ofdrugs thatare
normally prescribed for the treatment of attention deficit
hyperactivity disorder (ADHD) including methylphenidate
(Ritalin) and other amphetaminelike stimulants, which are
believed to improve cognitive performance (Greely et al.
2008b;M a h e r2008). This has raised concern regarding the
ethical and safety aspects of potential cognition-enhancing
drugs (Greely et al. 2008a; Larriviere et al. 2009;S a h a k i a n
and Morein-Zamir2007).These issuesaside,itisimportant to
know if these drugs do actually have cognition-enhancing
effects in healthy subjects.
Methylphenidate inhibits the reuptake of the catecholamines
dopamine and noradrenaline by blocking the transporters and
thus, enhances catecholamine availability (Hannestad et al.
2010; Volkow et al. 1998). Methylphenidate treatment does
not only reduce behavioral symptoms in children with ADHD
but also improvestheircognitive function(Pietrzaketal.2006).
There are also observations of methylphenidate-induced cog-
nition enhancement in healthy adults (Elliott et al. 1997;M e h t a
et al. 2000), although studies in this area are relatively sparse.
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nitive function in healthy volunteers have mainly focused on
cognitive domains which are known to be affected in ADHD
or to involve dopaminergic action. These include attention,
response inhibition, planning and (working) memory (Cools
and Robbins 2004; Luciana and Collins 1997; Luciana et al.
1992; Mehta et al. 1999;P i e t r z a ke ta l .2006). One aspect of
attention studied in healthy volunteers is divided attention.
Methylphenidate has been observed to improve performance
onadividedattentiontask,inwhichparticipantshavetotracka
moving target with a joystick and simultaneously press a
button in response to the appearance of a visual stimulus
(Bishop et al. 1997;R o e h r se ta l .1999). These effects were
most prominent when participants were sleep-deprived.
Attentional control has been assessed in healthy volunteers
using an intradimensional/extradimensional shift task, which
requires participants to make visual discriminations while
stimulus characteristics vary along different dimensions and
the relevant dimension reverses between different task stages
(Rogers et al. 1999). Although Elliott et al. (1997)f o u n dn o
effect of methylphenidate on this task, Rogers et al. (1999)
observed an enhanced ability to reallocate attention towards
newly relevant features of environmental stimuli after
methylphenidate.
Response inhibition, as assessed in a Go–NoGo task has
been shown to improve with methylphenidate in older adults
(Ben-Itzhak et al. 2008). Planning is also observed to be
affectedbymethylphenidate inhealthy adults. Intwo versions
of the Tower of London task, enhanced performance was
observed when methylphenidate was administered in the first
of two sessions as opposed to impaired performance when the
drug was taken in the second session (and placebo in the first,
(Elliott et al. 1997)). Elliott et al. explain this result hypothe-
sizing that methylphenidate enhances performance on novel
tasks but impairs performance on familiar tasks.
There are several reports of improved performance on both
nonspatial and spatial working memory tasks after methyl-
phenidate administration in healthy adults. For example,
methylphenidate enhances performance on the Sternberg
memory scanning task, in which participants are asked to
judge whether probe letters were in the memory set that was
learned atthe beginning ofthe task(Brumaghimand Klorman
1998;Fitzpatricketal.1988).Improvementofspatialworking
memory has been observed within a self-ordered search task
in which participants search for tokens in an array of boxes
displayed on a computer screen (Elliott et al. 1997;M e h t ae t
al. 2000).
Besides the domains described above, few researchers have
studied the influence of methylphenidate on immediate and
delayedrecallofwordlists(Bray etal.2004;C a mp - B r u noan d
Herting 1994; Hermens et al. 2007; Kuypers and Ramaekers
2005), none of whom found a significant effect. This is sur-
prising as methylphenidate is known to enhance delayed recall
of word lists in ADHD (Evans et al. 1986). The pharmacolog-
ically similar compound amphetamine has shown to improve
consolidation and retention of word lists while leaving acqui-
sition unaffected (Advokat 2010). Experiments from Soetens
and Zeeuws (Soetens et al. 1995; 1993; Zeeuws and Soetens
2007) haveshown thatamphetamine facilitates verbal memory
recall if it is active in the brain during the consolidation phase
(Soetens et al. 1995). Additional experiments showed that the
effect increases with longer presentation time of the words,
lasts at least 3 days, is independent of retrieval and generalizes
torecognition(Soetensetal.1995;Zeeu wsetal.2010;Zeeu ws
and Soetens 2007).
Importantly, task procedures used by Soetens and Zeeuws
were rather different from those used in the methylphenidate
studies cited above. Hermens et al., Kuypers and Ramaekers
and Bray et al. used word lists containing only 12 or 15 items.
In combination with repeated presentations (three or four
times), this may have led to a ceiling effect in performance.
In line with this notion, using lists of 24 easy nouns that were
presented only once, Camp-Bruno and Herting (1994)d i d
observe improved performance in both immediate and
delayed recall, although this effect was not significant.
The aim of the current study was to find out whether
enhancedword recall could be observed after methylphenidate
with a more optimal experimental design. In order to avoid
possibleceilingeffectssuspectedtohaveinfluencedthestudies
mentioned above, a 30-word learning test was used in the
current study. Performance on the 30 word lists of the visual
verbal learning task was tested in 19 healthy volunteers after
10,20or40mgofmethylphenidateandplacebo.Togetamore
completeviewofmethylphenidate’s cognitive effects, notonly
extending previous findings but also putting current effects of
methylphenidate on word learning into perspective, additional
cognitive tasks were administered. These additional tasks were
carefully selected to represent the most relevant cognitive
domains, both with respect to the most common clinical appli-
cation of methylphenidate (i.e., treatment of ADHD) and do-
paminergic involvement. Hence, we included tasks assessing
attention, response inhibition, planning and working memory.
The design of the current study, using three different doses
of methylphenidate in a placebo-controlled within-subjects
experiment allows examination of the a dose–response rela-
tionship for this drug and its effect on cognition. It addresses
some methodological issues observed in other studies using
only a single dose or comparing different doses in parallel
groups (Elliott et al. 1997; Mehta et al. 2000). Dose-related
effects of moderate to high doses of methylphenidate on mem-
ory consolidation were expected to be reflected by better
delayed recall. Performance on the other tasks was also
expected to improve after moderate to high doses of methyl-
phenidate. Based on the effect of methylphenidate on psycho-
motor function, it was expected that improved performance on
these tasks may mainly be reflected by faster response times.
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Participants
Nineteen healthy male volunteers (mean age 023.4, SD 05.4,
range 019–37) were selected and paid to participate. Partic-
ipants were recruited by means of local advertisements. Pre-
screening occurred using a medical history questionnaire and
was followed by medical examination.
The main inclusion criteria were: between 18 and 40years
of age, body mass index between 18 and 30 kg/m
2 and right-
handedness. The main exclusion criteria were history or
presence of mental or physical disorders, consumption of
more than 21 alcohol units per week or more than five
caffeine-containing drinks per day. In addition, volunteers
with polymorphisms of the CES1 gene indicative of being a
poor metabolizer of methylphenidate were excluded. One
participant was excluded based on this criterion.
All subjects gave written informed consent. The study was
carried out inaccordance with the Declaration ofHelsinki and
approved by the medical ethical committee of Maastricht
University.
Design
The study was conducted according to a double-blind,
placebo-controlled, four-way crossover design. Between the
testing days, a period of at least 48 h elapsed, but generally,
testingdayswerescheduledapproximately1weekapart.Each
participant received one of four single treatments including
placebo (PLA) and 10, 20 and 40 mg methylphenidate (M10,
M20 and M40) on each testing day. The order of the treat-
ments was randomized following a Williams Latin Square
design resulting in four different sequences.
Visual verbal learning test
This task is an adapted version of Rey’s Auditory Verbal
Learning Test (Lezak 1995). The VVLTwas used to measure
declarative memory. It included 30 words that were presented
on a computer screen (stimulus presentation time and inter-
stimulus interval were 1,000 ms, (Klaassen et al. 2002)). This
presentationwasrepeatedthreetimesusingthesamesequence
of words, each time followed by immediate free recall of all
rememberedwords.Thirtyminutes after immediatefreerecall
of the final series, participants were subjected to a delayed
recall test and a recognition test. During the latter, 30 words
were presented, 15 of which were previously presented and
another 15 that were new. Outcome measures of the immedi-
ate and delayed recall tests were total number of correctly
recalled words during immediate recall (summed over three
trials) and number of correctly recalled words during delayed
recall. The dependent measures of the recognition test were
median reaction time, measured in milliseconds and sensitiv-
ity (A’). A’ is calculated as follows: A0 ¼ 1   1=4f r =crþ ½
1   cr ðÞ = 1   fr ðÞ   ,w i t hf r0 falsely recognized words and
cr 0 correctly recognized words.
Spatial working memory task
The ‘Object relocation’ program was usedas a spatialworking
memory task (Kessels et al. 1999; 2000). In this task, partic-
ipants were required to relocate ten visual stimuli (small draw-
ingsofobjectssuchasacarora flower)thatwerepresented on
a computer screen in a 15-cm
2 sized square to their original
location. The taskconsistedoftwo parts. Inthefirst part, called
‘object to position’ or OTP, participants had 15 s time to
memorize the locations of the objects and were asked to drag
theobjectstothecorrectpositions,whichwerecuedwithblack
dots.Inthesecondpart,thecombined(COM)part,participants
had30s tomemorizethelocations andthistime, there were no
cues to indicate the previous positions. Participants were
instructed to place the objects in their original position as
accurately as possible. In both parts, there was no time limit
for the relocation of the stimuli. The dependent variables were
percentage correct for OTP and percentage correct, absolute
error and positional fit for COM. In the COM part, percentage
correct was calculated such that relocation would be correct
when the object was placed within 20 mm from the original
location. Absolute error was the absolute distance in milli-
meters an object was relocated away from its original position.
Positional fit measured the ability to remember the locations
per se, independent from the ability to remember which object
wasineachlocationandcomputedasthebestfitscoreyielding
the smallest distance error for the stimulus as a whole.
Set shifting task
The set shifting task used in this study combined the methods
of Müller and Townsend (Muller et al. 2007;T o w n s e n de ta l .
2006). The task measured cognitive flexibility and the influ-
ence of reward. Participants were presented with a stream of
auditory and visual stimuli including light and dark blue
squares on a computer screen and high and low tones through
headphones (stimulus presentation time was 150 ms and inter-
stimulusintervalwas850ms).Assignmentssoastorespondto
the tones (‘Hear trials’) or the squares (‘Look’ trials) were
interspersed with the stimuli and presented for 1,000 ms. Par-
ticipants were told to respond only to the dark blue square and
the high tones, while ignoring the light blue squares and low
tones. In half of the trials, a ‘€’ sign on the computer screen
indicated that if they would perform verywell (correct and fast
responses), they would earn an additional monetary reward
(awarded to the best performer in the study). The experiment
contained six blocks, of which three were ‘reward blocks’ and
three were ‘nonreward blocks’. Each block contained 56
Psychopharmacology (2012) 221:611–619 613stimuliandswitchingoccurredafteravariablenumberoftrials,
ranging between five and nine trials. The sequence of blocks
was randomized between participants and sessions. After a
block containing the reward stimuli, the participants received
feedback on how well they performed. Participants were
expected to respond faster in the reward than in the control
conditions. Dependent measures were response times in cor-
rect trials and percentage of correct responses. These were
calculated separately for the four different trial types: Look in
the reward blocks; Look in the nonreward blocks; Hear in the
reward blocks; and Hear in the nonreward blocks.
Stop signal task
Thestopsignaltaskwasusedtomeasuremotorimpulsivityand
a d a p t e df r o mt h a tu s e db yF i l l m o r ea n dR u s h( 2002). In this
task, participants were required to respond to go signals and
inhibit the response when a stop signal was presented. On a
computer screen, the go signals were visually presented letters,
A, B, C and D (stimuli were presented for 500 ms or until the
participant responded; interstimulus interval was 1,500 ms).
The stop signal was the visual presentation of a ‘*’at one of
the corners of the screen. Participants were instructed to re-
spond as fast as possible with left (to A and C) and right (to B
and D) index fingers. Stop signals were presented at delays of
50,150,250,and350ms.Asingletestconsistedof176trials in
which each of the four-letter stimuli was presented equally
often. A stop signal occurred in 48 trials during a test. Depen-
dentvariablesweretheproportionofcommissionerrorsonstop
trials and the reaction times on go and stop-signal trials (i.e.,
stop reaction time). Reaction time to stop-signal trials repre-
sented the estimated mean time required to inhibit a response.
The method for calculating stop reaction time was taken from
the race model of inhibitory control (Logan 1994). Stop reac-
tion time was calculated by subtracting the stop-signal delay
from the reaction time on go trials associated with the nth
percentile of the reaction time distribution. The nth percentile
corresponds to the percentage of commission errors (Logan
1994; Ramaekers et al. 2011).
Tower of London
Planning ability was assessed by a computerized version of the
Tower of London task (Sobczak et al. 2002). On a computer
screen, two arrays of differently colored balls (red, yellow and
blue) on sticks were presented until the subject responded. The
subject was requested to indicate the minimal number of steps
necessary to rearrange the balls on the lower configuration to
match the arrangement presented on the top half of the screen.
The subjects had to count the number of moves and then
respond by pressing the appropriate response button (two to
six steps) as quickly as possible. The complexity of the task
was dependent on the minimal number of steps in which the
rearrangement could be achieved: two, three, four and five
steps and sometimes six steps, to avoid guessing (only two to
five are analyzed). Performance was indicated by the slope
coefficient of the linear regression of the median response time
as a function of the number of steps. In addition, percentage
correct and response time calculated per number of minimally
required steps were taken into account.
Procedure
Thecurrentstudywasintegratedinalargerstudyontheeffects
of methylphenidate on the Contingent Negative Variation
(Linssen et al. 2011). A training session in which the tasks
were practiced took place within 2 weeks before the first
testing day. Participants abstained from alcohol during the last
24 h prior to each testing day. On testing days, they were
collectedat theirhomeandarrivedatthelabinfastedcondition
at either 8.00 am or 8:30 am. Inclusion and exclusion criteria
were checked. Next, participants were given a standardized
meal for breakfast at 80 min predose (t0−80). At t0−30, stop
signal, set shifting and spatial working memory tests were
administered to get a baseline measurement. At t00 partici-
pantsingestedfourcapsuleswithwater,whichcontainedeither
PLA, M10, M20 or M40. The stop signal, set shifting and
spatial working memory tests were administered again at t090
and t0270. The verbal word learning test and the Tower of
London were administered at t0150, followed by delayed
recall and recognition testing of the words approximately
30 min later. At the end of the testing day, participants were
returned to their home.
Data analysis
Data were analyzed using a repeated measures analysis of
variance. Because one subject dropped out, there was a min-
imal deviation from complete balancing of treatment orders
(order1 0 PLA, M10, M20, M40 (five participants), order 2 0
M10, M40, PLA, M20 (five participants), order 3 0 M20,
PLA, M40, M10 (four participants) and order 4 0 M40, M20,
M10,PLA(fiveparticipants)).Forthisreason,treatmentorder
was entered as a between-subjects factor. Since treatment
consisted of different doses of the same drug, main effects of
the drug were not evaluated. Instead, a prioriplanned compar-
isons between each dose relative to placebo were tested for
significance, at p<0.05usingLSDcorrection.
Results
Visual verbal learning test
Mean values of dependent measures of the visual verbal
learning task are presented in Fig. 1. Methylphenidate had
614 Psychopharmacology (2012) 221:611–619no effect on immediate recall. However, delayed recall
improved after M20 (F1,1404.937, p<0.05) and M40
(F1,1406.084, p<0.03) compared to placebo.
Median reaction time on the recognition test was slower
after M40 (F1,1405.953, p<0.05). Sensitivity was higher
after 40 mg of methylphenidate (F1,1404.878, p<0.05).
Spatial working memory task
Methylphenidate did not significantly affect spatial working
memory task performance (Table 1).
Set shifting task
Methylphenidate did not affect response time and percentage
correct in the ‘look’ trials in the reward blocks. In the non-
reward blocks, there was also no effect of the drug on percent-
age correct. However, methylphenidate led to faster responses
on the ‘look’ trials of the nonreward blocks after M40 at T90
(F1,1509.589,p<0.01) andafter M10and M40, at T270 (M10:
F1,1405.363, p<0.04, M40: F1,14014.145, p<0.01).
Responses to ‘hear’ trials were faster in the nonreward
parts of the task at T270 (M401,1406.885, p<0.03). Meth-
ylphenidate improved performance in the hear trials in both
reward (M40: F1,15010.261, p<0.01) and nonreward trials
(M20: F1,1504.713, p<0.05, M40: F1,1505.809, p<0.03) at
T90 and reward trials at T270 (M40: F1,1406.764, p<0.03).
Stop signal task
A dose of 20 mg of methylphenidate led to faster go and
stop responses at T270 (go: F1,1405.479, p<0.04; stop:
F1,1409.341, p<0.01). Performance on this task, as mea-
sured by percentage correct, was improved after M40 in stop
trials at T90 (F1,15010.698, p<0.01).
Tower of London
Methylphenidate only positively affected performance of
trials that could be solved in three steps when given at a
dose of 20 mg (F1,1505.065, p<0.05). Participants
responded faster after M10 and in the trials that could be
solved in five steps (M10: F1,1507.616, p<0.02) (Table 2).
Discussion
In this dose–response study, different doses of methylphe-
nidate were tested for their effect on memory and other
cognitive functions in healthy volunteers. Methylphenidate
improved delayed recall of word lists. In addition, set shift-
ing and stop signal test performance improved after meth-
ylphenidate. Methylphenidate had little effect on the Tower
of London task performance and no effect on performance
of the spatial working memory task.
Fig. 1 Means of dependent
measures (a total number of
correctly recalled words in
immediate recall; b number of
words recalled in delayed
recall; c median response time
in recognition test; d sensitivity
of recognition test) of the word
learning test after placebo and
methylphenidate, 10, 20 and
40 mg (PLA, M10, M20 and
M40, respectively). Significant
differences relative to placebo
are indicated by an asterisk
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616 Psychopharmacology (2012) 221:611–619Based on earlier findings of enhanced declarative mem-
ory consolidation after amphetamine, it was expected that
methylphenidate would improve performance on the 30-
word learning test. Results of the current study confirmed
this expectation. Participants recalled more words in the
delayed recall test after 20 and 40 mg of methylphenidate
compared to placebo. Since no improvement was observed
at immediate recall, enhanced delayed recall is likely caused
by better consolidation. To the best of our knowledge, we
are the first to report better consolidation of word lists after
methylphenidate in healthy adults. Since previous studies
used similar doses (20 or 45 mg), suboptimal dosing is an
unlikely explanation for the lack of performance-enhancing
effects in those studies. An important factor may be word
list length. When testing memory in healthy volunteers, a
ceiling effect is easily reached if relatively short lists are
presented repeatedly. Since it was hypothesized that en-
hanced dopamine activity induced by methylphenidate
may lead to improved word learning test performance, the
use of lists of 12 to 15 words in previous studies (Bray et al.
2004; Hermens et al. 2007; Kuypers and Ramaekers 2007)
may have left no room for improvement.
There are ample indications of dopamine involvement in
(spatial) working memory (Ellis et al. 2007; Landau et al.
2008; Robbins 2005). Indeed, methylphenidate has been
shown to improve spatial working memory performance
(Elliott et al. 1997; Mehta et al. 2000). This effect was,
however, not replicated in the present study. A possibly
important difference between the self-ordered search tasks
used in previous studies and the spatial working memory
task used here is that encoding of spatial locations occurs
under time pressure in the current task. Previous research
has suggested that methylphenidate may induce activity and
arousal in healthy volunteers (Clark et al. 1986; Elliott et al.
1997). Hence, participants may have had difficulties to
encode information due to overarousal.
Methylphenidate generally improved performance of the
set shifting task, as was indicated by both faster responses
and a higher percentage of correct responses. Most effects
were observed on the hear trials, suggesting that methylphe-
nidate affected auditory attention more than visual attention.
It is unclear why this should be the case. Our expectation
that the effect of methylphenidate would be more pro-
nounced in the reward parts of this task was not confirmed.
Participants may not have paid attention to the ‘€’ sign,
which indicated that they were in the reward condition.
Methylphenidate improved stop signal task performance
as was indicated mainly by faster responses. Effects were
most prominent in the go trials. Faster responses (both in the
set shifting and the stop signal task) may partly reflect the
response readiness-enhancing effect of methylphenidate
(Linssen et al. 2011) increasing the speed of performance
(Elliott et al. 1997). Furthermore, taking into account the
relatively high number of statistical comparisons being
made in this study, some of the effects reported here includ-
ing those on the Tower of London task may not be genuine
drug effects. Therefore, the overall pattern of results was
considered when describing drug effects. Thus, generally,
MPH improved measures of declarative memory, attention
and response inhibition.
The effects of methylphenidate were observed within a
rather wide time window, between 90 and 270 min after drug
intake. This likely reflects a relatively long lasting enhance-
ment of dopamine levels in the blood after methylphenidate.
Blood dopamine levels cannot be measured directly, but
changes in prolactin level in blood are a good surrogate
marker, since the prolactin level is known to rise as the
dopamine level decreases and vice versa (Ben-Jonathan
1985). Indeed, prolactin levels were decreased between 60
and 240 min after methylphenidate administration in this
group of participants (Linssen et al. 2011).
Most studies into effects of dopaminergic drugs on
aspects of cognitive performance describe results according
to an inverted U curve when performance is mapped as a
function of degree of neurotransmitter activity (Levy 2009;
Mehta et al. 2004). The design of the present study, using
Table 2 Mean values (SEM) of
dependent measures of Tower of
London (ToL) after placebo and
methylphenidate 10, 20 and
40 mg (PLA, M10, M20 and
M40, respectively)
RT Response time
*p<0.05;
**p<0.1
T160
PLA M10 M20 M40
Slope 0.4 (0.0) 0.4 (0.0) 0.4 (0.3) 0.4 (0.0)
2 steps RT 4,277 (300) 4,356 (366) 4,458 (418) 4,760 (508)
% correct 95.8 (2.3) 95.9 (2.1) 95.1 (1.6) 94.9 (2.3)
3 steps RT 6,039 (502) 6,461 (333) 5,835 (446) 6,128 (583)
% correct 95.5 (1.4) 95.1 (1.9) 98.9
* (0.7) 94.5 (1.5)
4 steps RT 9,416 (895) 9,197 (861) 8,636 (715) 9,892 (1,153)
% correct 91.6 (2.3) 89.6 (2.1) 93.5 (2.2) 94.3 (2.7)
5 steps RT 13,458 (1007) 15,770 (1,231) 15,076 (1,321) 15,441 (1,291)
% correct 84.1 (3.3) 85.3
* (3.0) 79.8 (2.7) 85.4
** (3.3)
Psychopharmacology (2012) 221:611–619 617three doses of methylphenidate, the highest of which corre-
sponds to 75% blocking of dopamine reuptake sites (Volkow
et al. 1998) should allow to reveal the inverted U curve, if
present. This would be reflected by improved performance at
low and intermediate dosing levels and a drop in performance
enhancementatthehigherdose.However,thecurrentfindings
suggest that methylphenidate influences memory consolida-
tion ina monotonic positivefashion. Althoughdose–response
relationships may differ between cognitive domains, it has
been shown that methylphenidate effects on response readi-
ness cannot also be described in terms of the inverted U
function (Linssen et al. 2011). Methylphenidate’s enhancing
effects on response readiness were observed even after a dose
aslowas10mgandgrewmoreconsistentandprominentwith
increasing doses. Hence, our data challenge the existence of
the inverted U relationship, at least with respect to declarative
memory consolidation and response readiness.
In conclusion, this was the first study to find dose-related
effects of methylphenidate on declarative memory consolida-
tion. This result is in line with earlier described findings of
amphetamine-induced enhancementof memory consolidation.
Improved performance was also observed on stop signal and
set shifting tasks.
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